Porter v. Tap Pharmaceutical, et al

Filing 587

Judge Richard G. Stearns: ORDER entered for issuance of cy pres payment to DFCI in support of the Mazzone Awards Program. (Zierk, Marsha)

UNITED STATES DISTRICT COURT
DISTRICT OF MASSACHUSETTS
MDL NO. 1430
MASTER FILE NO. 01-CV-10861-RGS

IN RE: LUPRON® MARKETING AND
SALES PRACTICES LITIGATION
ORDER FOR ISSUANCE OF CY PRES
PAYMENT TO DANA FARBER CANCER INSTITUTE
IN SUPPORT OF THE MAZZONE AWARDS PROGRAM
January 13, 2015
STEARNS, D.J.
On August 6, 2010, this court awarded the surplus funds from the
Lupron® Class Settlement Pool to Dana-Farber/Harvard Cancer Center
(DF/HCC) and the Prostate Cancer Foundation (PCF) to be distributed
according to the terms of the proposal submitted to the court on May 20,
2010, as approved and modified by the court.

The Mazzone Awards

Program now supports the work of 137 investigators worldwide who are
involved in thirty-eight separate prostate cancer and related research
projects.

To further this work, the court directs the Court Registry

Investment System to issue a check in the amount of $2,000,000.00 to
Dana Farber Cancer Institute d/b/a Dana-Farber/Harvard Cancer Center
to be deposited into a dedicated account and used for the purposes

identified in the court’s August 6, 2010 Order. The court will disperse the
balance of the fund upon its approval of the next research progress and
accounting report in December of 2015, holding back a small amount
pending any administrative issues, until DFCI’s final reconciliation of the
awarded funds.
SO ORDERED.
/s/ Hon. Richard G. Stearns
UNITED STATES DISTRICT JUDGE